These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 29567948

  • 21. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
    Sapkota BR, Ranjit C, Macdonald M.
    Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
    [Abstract] [Full Text] [Related]

  • 22. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
    Lavania M, Jadhav RS, Chaitanya VS, Turankar R, Selvasekhar A, Das L, Darlong F, Hambroom UK, Kumar S, Sengupta U.
    Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
    [Abstract] [Full Text] [Related]

  • 23. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
    Andrade ESN, Brandão JG, Silva JSD, Coriolano CRF, Rosa PS, Moraes MO, Ferreira CO, Gomes CM, Araújo WN.
    Antimicrob Agents Chemother; 2022 May 17; 66(5):e0217021. PubMed ID: 35435708
    [Abstract] [Full Text] [Related]

  • 24. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI, Colorado CL, Torres JF, León CI.
    Biomedica; 2014 Apr 17; 34 Suppl 1():137-47. PubMed ID: 24968045
    [Abstract] [Full Text] [Related]

  • 25. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
    Chhabra S, Narang T, Sahu S, Sharma K, Shilpa S, Sharma A, Jain S, Singh I, Yadav R, Kaur M, Sharma R, Nadeem M, Pandey P, Minz RW, Dogra S.
    J Glob Antimicrob Resist; 2023 Dec 17; 35():262-267. PubMed ID: 37852372
    [Abstract] [Full Text] [Related]

  • 26. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
    Hernández E, Cardona-Castro N, Rodríguez G, Villegas S, Beltrán C, Kimura M, Vissa VD, Gómez Y.
    Rev Panam Salud Publica; 2008 Feb 17; 23(2):73-7. PubMed ID: 18371276
    [Abstract] [Full Text] [Related]

  • 27. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
    Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, Rosa PS, Williams D, Gupta UD, Lavania M, Cardona-Castro N, Miyamoto Y, Hagge D, Srikantam A, Hongseng W, Indropo A, Vissa V, Johnson RC, Cauchoix B, Pannikar VK, Cooreman EAWD, Pemmaraju VRR, Gillini L, WHO surveillance network of antimicrobial resistance in leprosy.
    Clin Microbiol Infect; 2018 Dec 17; 24(12):1305-1310. PubMed ID: 29496597
    [Abstract] [Full Text] [Related]

  • 28. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B, Arunagiri K, Kumar BN, Narayanan S, Menaka K, Oommen PK.
    Lepr Rev; 2011 Mar 17; 82(1):36-45. PubMed ID: 21644470
    [Abstract] [Full Text] [Related]

  • 29. Mutation at codon 442 in the rpoB gene of Mycobacterium leprae does not confer resistance to rifampicin.
    Lavania M, Hena A, Reja H, Nigam A, Biswas NK, Singh I, Turankar RP, Gupta U, Kumar S, Rewaria L, Patra PK, Sengupta U, Bhattacharya B.
    Lepr Rev; 2016 Mar 17; 87(1):93-100. PubMed ID: 27255062
    [Abstract] [Full Text] [Related]

  • 30. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
    Chen X, He J, Liu J, You Y, Yuan L, Wen Y.
    PLoS Negl Trop Dis; 2019 Dec 17; 13(12):e0007946. PubMed ID: 31881061
    [Abstract] [Full Text] [Related]

  • 31. Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India.
    Lavania M, Nigam A, Turankar RP, Singh I, Gupta P, Kumar S, Sengupta U, John AS.
    Clin Microbiol Infect; 2015 Dec 17; 21(12):e85-6. PubMed ID: 26314915
    [No Abstract] [Full Text] [Related]

  • 32. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
    Cambau E, Bonnafous P, Perani E, Sougakoff W, Ji B, Jarlier V.
    Clin Infect Dis; 2002 Jan 01; 34(1):39-45. PubMed ID: 11731943
    [Abstract] [Full Text] [Related]

  • 33. A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
    Honoré N, Perrani E, Telenti A, Grosset J, Cole ST.
    Int J Lepr Other Mycobact Dis; 1993 Dec 01; 61(4):600-4. PubMed ID: 8151192
    [Abstract] [Full Text] [Related]

  • 34. Computational saturation mutagenesis to predict structural consequences of systematic mutations in the beta subunit of RNA polymerase in Mycobacterium leprae.
    Vedithi SC, Rodrigues CHM, Portelli S, Skwark MJ, Das M, Ascher DB, Blundell TL, Malhotra S.
    Comput Struct Biotechnol J; 2020 Dec 01; 18():271-286. PubMed ID: 32042379
    [Abstract] [Full Text] [Related]

  • 35. Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
    Li W, Sakamuri RM, Lyons DE, Orcullo FM, Shinde V, Dela Pena EL, Maghanoy AA, Mallari IB, Tan EV, Nath I, Brennan PJ, Balagon M, Vissa V.
    Antimicrob Agents Chemother; 2011 Nov 01; 55(11):5384-7. PubMed ID: 21859943
    [Abstract] [Full Text] [Related]

  • 36. Active surveillance of leprosy contacts in country with low prevalence rate.
    Kai M, Maeda Y, Maeda S, Fukutomi Y, Kobayashi K, Kashiwabara Y, Makino M, Abbasi MA, Khan MZ, Shah PA.
    Int J Lepr Other Mycobact Dis; 2004 Mar 01; 72(1):50-3. PubMed ID: 15217314
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
    Lopez-Roa RI, Fafutis-Morris M, Masanori M.
    Rev Latinoam Microbiol; 2006 Mar 01; 48(3-4):256-9. PubMed ID: 18293659
    [Abstract] [Full Text] [Related]

  • 39. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
    Marijke Braet S, Jouet A, Aubry A, Van Dyck-Lippens M, Lenoir E, Assoumani Y, Baco A, Mzembaba A, Cambau E, Vasconcellos SEG, Rigouts L, Suffys PN, Hasker E, Supply P, de Jong BC.
    Lancet Microbe; 2022 Sep 01; 3(9):e693-e700. PubMed ID: 35850123
    [Abstract] [Full Text] [Related]

  • 40. Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas State, Brazil.
    Contreras Mejía Mdel C, Porto Dos Santos M, Villarouco da Silva GA, da Motta Passos I, Naveca FG, Souza Cunha Mda G, Moraes MO, de Paula L.
    J Clin Microbiol; 2014 Dec 01; 52(12):4359-60. PubMed ID: 25274993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.